The American College of Rheumatology (ACR) has released recommendations for the treatment of rheumatoid arthritis. The 2012 ACR recommendations, an update of the 2008 recommendations, focuses on the use of disease-modifying anti-rheumatic drugs (DMARDs) and biologic drugs for rheumatoid arthritis.
Patients often are confused by certain issues, such as when they should start a DMARD or biologic drug, how long they should stick with a particular medication, or when they should switch to another drug. The recommendations address those and other issues. Learn more in Rheumatoid Arthritis Treatment - 2012 ACR Recommendations.
Related Articles:
- The Facts of DMARDs
- Biologics Explained
- Self-Injection of Arthritis Drugs
- TNF Blockers - Test Your Knowledge
Join the Discussion: Arthritis Forum
Follow Us: Twitter and Facebook
Sign Up: Free Arthritis Newsletter
No comments:
Post a Comment